BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19698230)

  • 1. [Effect of demethylating treatment on cytotoxicity of NK-92MI cells].
    Gao XN; Wang LL; Lin J; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):924-8. PubMed ID: 19698230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of demethylation treatment on the expression of inhibitory receptor KIR gene in NK-92MI cell line].
    Gao XN; Lin J; Wang LL; Gao L; Jin HJ; Sun JF; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):656-60. PubMed ID: 19549382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis].
    Guo KY; Mei JZ; Yao KT
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):247-9. PubMed ID: 17425963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Promoter methylation regulates KIR3DL1 gene expression in NK-92MI cell line].
    Gao XN; Yu L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jul; 24(7):668-71. PubMed ID: 18616907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Killer immunoglobulin-like receptor gene genotype and expression pattern in NK-92MI and K562 cells].
    Dou LP; DA WM; Liu JH; Sun JF; Zhao Y; Wang QS; Gao CJ; Yu L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Sep; 25(9):767-9. PubMed ID: 19737456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential contribution of education through KIR2DL1, KIR2DL3, and KIR3DL1 to antibody-dependent (AD) NK cell activation and ADCC.
    Lisovsky I; Kant S; Tremblay-McLean A; Isitman G; Kiani Z; Dupuy FP; Gilbert L; Bruneau J; Shoukry NH; Lebouché B; Bernard NF
    J Leukoc Biol; 2019 Mar; 105(3):551-563. PubMed ID: 30698860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their iKIR Negative Counterparts.
    Isitman G; Tremblay-McLean A; Lisovsky I; Bruneau J; Lebouché B; Routy JP; Bernard NF
    PLoS One; 2016; 11(10):e0164517. PubMed ID: 27732638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-lymphoma cells escape rituximab-triggered elimination by NK cells through increased HLA class I expression.
    Borgerding A; Hasenkamp J; Engelke M; Burkhart N; Trümper L; Wienands J; Glass B
    Exp Hematol; 2010 Mar; 38(3):213-21. PubMed ID: 20056126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective reduction of natural killer cells and T cells expressing inhibitory receptors for MHC class I in the livers of patients with hepatic malignancy.
    Norris S; Doherty DG; Curry M; McEntee G; Traynor O; Hegarty JE; O'Farrelly C
    Cancer Immunol Immunother; 2003 Jan; 52(1):53-8. PubMed ID: 12536240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demethylating treatment suppresses natural killer cell cytolytic activity.
    Gao XN; Lin J; Wang LL; Yu L
    Mol Immunol; 2009 Jun; 46(10):2064-70. PubMed ID: 19394699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KIR downregulation by IL-12/15/18 unleashes human NK cells from KIR/HLA-I inhibition and enhances killing of tumor cells.
    Ewen EM; Pahl JHW; Miller M; Watzl C; Cerwenka A
    Eur J Immunol; 2018 Feb; 48(2):355-365. PubMed ID: 29105756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors.
    Leung W; Iyengar R; Triplett B; Turner V; Behm FG; Holladay MS; Houston J; Handgretinger R
    J Immunol; 2005 May; 174(10):6540-5. PubMed ID: 15879158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-Cw4 expression on porcine endothelial cells reduces cytotoxicity and adhesion mediated by CD158a+ human NK cells.
    Forte P; Baumann BC; Schneider MK; Seebach JD
    Xenotransplantation; 2009; 16(1):19-26. PubMed ID: 19243557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Killer immunoglobulin-like receptor gene genotype and expression pattern in healthy people].
    Dou LP; DA WM; Huang WR; Li HH; Zhao Y; Wang QS; Gao CJ; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):132-5. PubMed ID: 20137133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of NKG2D ligands in multidrug-resistant nasopharyngeal carcinoma cell line CNE2/DDP and their effects on cytotoxicity of natural killer cells].
    Mei JZ; Guo KY; Wei HM; Song CY
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jun; 27(6):887-9. PubMed ID: 17584663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation.
    David G; Djaoud Z; Willem C; Legrand N; Rettman P; Gagne K; Cesbron A; Retière C
    J Immunol; 2013 Nov; 191(9):4778-88. PubMed ID: 24078689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3.
    Hilton HG; Vago L; Older Aguilar AM; Moesta AK; Graef T; Abi-Rached L; Norman PJ; Guethlein LA; Fleischhauer K; Parham P
    J Immunol; 2012 Aug; 189(3):1418-30. PubMed ID: 22772445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KIR2DL3 and KIR2DL1 show similar impact on licensing of human NK cells.
    Sim MJ; Stowell J; Sergeant R; Altmann DM; Long EO; Boyton RJ
    Eur J Immunol; 2016 Jan; 46(1):185-91. PubMed ID: 26467237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of NK cell subset distribution in normal and lymphoproliferative disease of granular lymphocyte conditions.
    Pascal V; Schleinitz N; Brunet C; Ravet S; Bonnet E; Lafarge X; Touinssi M; Reviron D; Viallard JF; Moreau JF; Déchanet-Merville J; Blanco P; Harlé JR; Sampol J; Vivier E; Dignat-George F; Paul P
    Eur J Immunol; 2004 Oct; 34(10):2930-40. PubMed ID: 15368309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL.
    Bakker AB; Phillips JH; Figdor CG; Lanier LL
    J Immunol; 1998 Jun; 160(11):5239-45. PubMed ID: 9605119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.